| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Streptomyces griseus (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Streptomyces griseus co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Chlamydiae |
| Chlamydia muridarum (chlamydias) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Folic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR0742
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Chlamydia muridarum co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4], [5] |
| Bacteria: Firmicutes |
| Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Menadione |
Click to Show/Hide the Detail |
| Drug ID |
DR1022
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Faecalibacterium prausnitzii co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
| Lactobacillus casei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Folic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR0742
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Lactobacillus casei co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [7], [8] |
| Bacteria: Proteobacteria |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Escherichia coli co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
| Folic acid |
Click to Show/Hide the Detail |
| Drug ID |
DR0742
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Escherichia coli co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [10], [11] |
| Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Klebsiella pneumoniae co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
| Raoultella planticola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Doxorubicin |
Click to Show/Hide the Detail |
| Drug ID |
DR0546
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Raoultella planticola co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Menadione |
Click to Show/Hide the Detail |
| Drug ID |
DR1022
Drug Info
|
| Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Salmonella enterica co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [12], [13] |
|
|
|
|
|
|